Sanofi S.A. (Paris, France). 2024 revenue ~€43B. Dupixent (immunology), Keytruda partnership. Vaccines: influenza, polio. Rare disease: Genzyme. API manufacturing in France, Germany, China.
12:40:39 AM · Jul 9, 2026
Sign in to reply and join the conversation.